Clearwater Capital Advisors, LLC Immunity Bio, Inc. Transaction History
Clearwater Capital Advisors, LLC
- $967 Million
- Q4 2024
A detailed history of Clearwater Capital Advisors, LLC transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Clearwater Capital Advisors, LLC holds 846,419 shares of IBRX stock, worth $2.09 Million. This represents 0.22% of its overall portfolio holdings.
Number of Shares
846,419
Previous 482,549
75.41%
Holding current value
$2.09 Million
Previous $1.79 Million
21.01%
% of portfolio
0.22%
Previous 0.18%
Shares
11 transactions
Others Institutions Holding IBRX
# of Institutions
234Shares Held
82.4MCall Options Held
1.02MPut Options Held
2.25M-
Vanguard Group Inc Valley Forge, PA17.3MShares$42.8 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$28.2 Million0.0% of portfolio
-
State Street Corp Boston, MA9.79MShares$24.2 Million0.0% of portfolio
-
Morgan Stanley New York, NY4.01MShares$9.89 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.84MShares$9.49 Million0.0% of portfolio
About ImmunityBio, Inc.
- Ticker IBRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 400,304,000
- Market Cap $989M
- Description
- ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...